Compare ACON & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACON | PAVS |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0M | 5.5M |
| IPO Year | 2022 | 2018 |
| Metric | ACON | PAVS |
|---|---|---|
| Price | $1.59 | $2.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $7.63 | N/A |
| AVG Volume (30 Days) | 12.9K | ★ 39.6K |
| Earning Date | 11-24-2026 | 12-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $75,730.00 | N/A |
| Revenue This Year | $44.55 | $541.46 |
| Revenue Next Year | $123.97 | $1.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.62 | N/A |
| 52 Week Low | $1.54 | $0.02 |
| 52 Week High | $9.36 | $26.69 |
| Indicator | ACON | PAVS |
|---|---|---|
| Relative Strength Index (RSI) | 33.47 | 35.12 |
| Support Level | N/A | $2.45 |
| Resistance Level | $3.54 | $4.18 |
| Average True Range (ATR) | 0.11 | 0.31 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 9.62 | 0.00 |
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.